Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Y Rha

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Clinical & Experimental Metastasis|November 1, 1996
Sequential activation and production of matrix metalloproteinase-2 during breast cancer progressionK S Lee, S Y Rha, S J Kim, et al.
Breast Cancer Research and Treatment|April 1, 1997
Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progressionS Y Rha, J H Kim, J K Roh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Effect of telomere and telomerase interactive agents on human tumor and normal cell linesS Y Rha, E Izbicka, R Lawrence, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2012
Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinomaY Koh, H Y Lim, J H Ahn, et al.
FEBS Letters|December 29, 2004
Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstructionM Yeo, S Y Rha, H C Jeung, et al.
British Journal of Cancer|November 24, 2012
Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysisJ Lee, S Hahn, D-W Kim, et al.
American Journal of Clinical Oncology|December 10, 1997
A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapyJ O Park, S Y Rha, N C Yoo, et al.
British Journal of Cancer|November 16, 2006
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimensH-C Jeung, S Y Rha, B C Cho, et al.
Breast Cancer Research and Treatment|January 1, 1997
P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancerH C Chung, S Y Rha, J H Kim, et al.
Oncology Reports|June 19, 1998
Different expression patterns of MMP-2 and MMP-9 in breast cancerS Y Rha, W I Yang, J H Kim, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Clinical & Experimental Metastasis|November 1, 1996
Sequential activation and production of matrix metalloproteinase-2 during breast cancer progressionK S Lee, S Y Rha, S J Kim, et al.
Breast Cancer Research and Treatment|April 1, 1997
Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progressionS Y Rha, J H Kim, J K Roh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Effect of telomere and telomerase interactive agents on human tumor and normal cell linesS Y Rha, E Izbicka, R Lawrence, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2012
Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinomaY Koh, H Y Lim, J H Ahn, et al.
FEBS Letters|December 29, 2004
Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstructionM Yeo, S Y Rha, H C Jeung, et al.
British Journal of Cancer|November 24, 2012
Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysisJ Lee, S Hahn, D-W Kim, et al.
American Journal of Clinical Oncology|December 10, 1997
A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapyJ O Park, S Y Rha, N C Yoo, et al.
British Journal of Cancer|November 16, 2006
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimensH-C Jeung, S Y Rha, B C Cho, et al.
Breast Cancer Research and Treatment|January 1, 1997
P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancerH C Chung, S Y Rha, J H Kim, et al.
Oncology Reports|June 19, 1998
Different expression patterns of MMP-2 and MMP-9 in breast cancerS Y Rha, W I Yang, J H Kim, et al.
Pageof 7